Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    -0.005 (-2.63%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Placing

21 Sep 2007 16:09

ValiRx PLC21 September 2007 ValiRx plc (the "Company") Placing of shares The Company announces that it is looking to raise in excess of £300,000 via aplacing of new ordinary shares of 6p each in the Company ("Ordinary Shares") at15.5p per share (the "Placing"). Application has been made for the Ordinary Shares to be admitted to trading onAIM and dealings are expected to commence on 27 September 2007 ("Admission"). Afurther announcement will be made before Admission confirming the final numberof shares issued under the Placing. Contact Details: ValiRx Plc WH Ireland Limited GTH Communications Dr Satu Vainikka David Youngman Toby Hall / Jade Mamarbachi +44 (0) 203 008 4416 +44 (0) 161 832 2174 +44 (0) 20 7153 8035 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th May 20182:56 pmRNSHolding(s) in Company
8th May 201812:13 pmRNSResult of AGM
4th May 20184:40 pmRNSSecond Price Monitoring Extn
4th May 20184:35 pmRNSPrice Monitoring Extension
4th May 20184:01 pmRNSPlacing and grant of warrants
26th Apr 20182:05 pmRNSSecond Price Monitoring Extn
26th Apr 20182:00 pmRNSPrice Monitoring Extension
25th Apr 20184:40 pmRNSSecond Price Monitoring Extn
25th Apr 20184:35 pmRNSPrice Monitoring Extension
25th Apr 20187:00 amRNSEU Patent Grant for Therapeutic Compound, VAL201
20th Apr 201810:45 amEQSHardman & Co Research: ValiRx (VAL): 2017: a pivotal year
19th Apr 20187:00 amRNSGENEICE & VAL101 Update
12th Apr 20187:00 amRNSNotice of AGM
10th Apr 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSUS Patent Grant for Therapeutic Compound, VAL201
19th Mar 20187:00 amRNSHolding(s) in Company
16th Mar 20183:01 pmRNSAppointment of Broker
2nd Mar 201811:01 amRNSStatement re broker
9th Feb 201811:57 amRNSIssue of options and directors dealings
2nd Feb 20184:26 pmRNSHolding(s) in Company
25th Jan 201812:06 pmRNSHolding(s) in Company
23rd Jan 20183:30 pmRNSHolding(s) in Company
16th Jan 20187:00 amRNSValiSeek Clinical Update (VAL401)
11th Jan 20187:00 amRNSUS Patent Notice of Allowance for Compound VAL201
4th Jan 20182:29 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSExercise of Warrants and Issue of Equity
27th Dec 201712:54 pmRNSFinal Loan Note Conversion and Issue of Equity
22nd Dec 20177:00 amRNSIssue of Equity
21st Dec 20179:16 amRNSResult of General Meeting
20th Dec 20173:58 pmRNSWarrant Exercise
20th Dec 20173:03 pmRNSWarrant Exercise
18th Dec 20178:45 amRNSWarrant Exercise
18th Dec 20177:00 amRNSre: VAL201 Clinical Trials
15th Dec 20177:00 amRNSExercise of Warrants and Issue of Equity
12th Dec 20177:00 amRNSValiSeek Clinical Development Update
11th Dec 20173:48 pmRNSLoan Note Conversion and Issue of Equity
6th Dec 20177:00 amRNSShareholder Circular and Notice of General Meeting
30th Nov 20172:38 pmRNSIssue of Equity
20th Nov 201711:23 amRNSHolding(s) in Company
15th Nov 20174:37 pmRNSYorkville CLN Conversion
11th Oct 20177:00 amRNSNotification of US Patent Allowance
5th Oct 20177:00 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSTotal Voting Rights
28th Sep 20177:00 amRNSValiSeek Clinical Development Update
27th Sep 20173:32 pmRNSHolding(s) in Company
26th Sep 20177:00 amRNSHalf-year Report
20th Sep 20173:18 pmRNSVAL201 update
19th Sep 20177:00 amRNSIssue of Equity
13th Sep 20179:34 amRNSHardman Research: GeneICE and VAL101 progress
7th Sep 20177:00 amRNSGeneICE & VAL101 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.